Petter Brodin
0000-0002-8103-0046
Publication & Citation Trends
Publications
241 total
Abstract 2055: Molecular profiling of the PI3Kδ inhibitor roginolisib in metastatic uveal melanoma and its correlation with clinical outcomes
Cited by 0
Semantic Scholar
164P Roginolisib (IOA-244), the first highly selective oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ), has immuno-modulatory effects associated with clinical benefits in patients with metastatic uveal melanoma OA
Cited by 1
Semantic Scholar
Roginolisib, an oral, highly selective and allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) in patients with uveal melanoma and advanced cancers.
Cited by 5
Semantic Scholar
Research Topics
Immune Cell Function and Interaction
(49)
T-cell and B-cell Immunology
(46)
SARS-CoV-2 and COVID-19 Research
(41)
COVID-19 Clinical Research Studies
(33)
Diabetes and associated disorders
(23)
Affiliations
University of Rome Tor Vergata
Uppsala University
Karolinska University Hospital
Emory University
Imperial College Healthcare NHS Trust